focus -WSS

focus

author：Wikipedia 2025-09-27 23:02:39 - browse：11

A person picking up medication at a drive through pharmacy window – biotech and pharma coverage from STAT — Adobe

On Tuesday morning, the Department of Health and Human Services unveiled its long-awaited list of the 10 medicines that will be subject to price negotiation in 2026 under the Inflation Reduction Act.

This will mark the first time that Medicare, the government program for paying for health care for older Americans, will have any ability to use its vast size to negotiate for lower prices. It’s not yet clear how big the discounts on these 10 drugs will be, or even if the law will hold up to multiple legal challenges from the pharmaceutical industry. It’s also not clear, as critics from the drug industry have noted, whether any savings to the government will be passed on to consumers.

Still, the naming of 10 medicines is a milestone, and a point to start appraising the impact of the law. The landscape here is complicated. No one really knows how the IRA’s price negotiation process will play out over the short and long term, and many companies who had products named were spared in other ways, with products many industry watchers expected to see on the list absent. Here is STAT’s assessment of who has won and lost.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Democrats decry new health bill for going easy on private equity

hotspot

WSS

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Boeing's 1st astronaut flight bumped into next year, more repairs needed

The haunting brain science of long Covid

What causes rare myocarditis in young men after Covid vaccines?

Democrats decry new health bill for going easy on private equity

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

knowledge

focus

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

A new crop of companies is reshaping the health data economy

Continuity nursing helped my family in our darkest PICU moments

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Former reverend arrested for allegedly killing 8

Bright Health sells Medicare Advantage business to Molina

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Hollywood unions extend contract negotiations for actors

Rise in cancer among younger people worries and puzzles doctors

leisure time

Trump Jan. 6 attorney John Lauro is ex

New Alzheimer's drugs heat up race for early detection blood tests

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

CDC Director Mandy Cohen on transparency, trust, and health

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

leisure time

knowledge

hotspot

focus